Podcast episode on phage therapy with Dr. Richard Alm at CARB-X
CARB-X Chief Scientist Dr. Richard Alm joins host Steven Yang for this episode of The Phage Therapy Today to help paint a broader picture of the antimicrobial landscape and discuss CARB-X’s investment strategies related to phage therapy. With the global biotech industry being a $800B dollar market in 2021, this episode follows the question what can be done to promote the scientific understanding of phage and phage therapy in this capital driven economy.
The Phage Therapy Today is a podcast series dedicated to leaders in the phage therapy industry. It presents insights into current advancements and challenges in this exciting sector from academia, financial, regulatory, manufacturing and entrepreneurial perspectives.
Each episode features accomplished guests serving various roles in developing our bacteriophage-evolved community.
Listen to the podcast episode: https://anchor.fm/phagetherapytoday/episodes/Investment-Strategies-in-Phage-Therapy-with-Dr–Richard-Alm-at-CARB-X-e1butla